NCT07488039 Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss
| NCT ID | NCT07488039 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kasr El Aini Hospital |
| Condition | Recurrent Anterior Shoulder Instability |
| Study Type | INTERVENTIONAL |
| Enrollment | 21 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 21 participants in total. It began in 2026-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn Labroplasty using the long head of biceps tendon works to patients with recurrent anterior shoulder instability with subcritical glenoid bone loss (\<20%) and thinned or deficient anterior labrum .The main questions it aims to answer are: Does Labroplasty using the long head of biceps improve the functional and radiological outcomes in patients with recurrent anterior shoulder instability with subcritical glenoid bone loss? Participants will: undergo arthroscopic labroplasty using the long head of biceps tendon Visit the clinic regularly for checkup and followup undergo MRI at 6 months to check radiological outcome
Eligibility Criteria
Inclusion Criteria: * patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation. * Franceschi types 2 and 3 labral defects * subcritical glenoid bone loss \<20% * positive anterior shoulder apprehension Exclusion Criteria: * Critical glenoid bones loss \>20% * Franceschi type 1 labral defect * concomitant long head of biceps tendon pathology * multidirectional instability * prior arthroscopic shoulder stabilization surgery * concomitant proximal humeral fractures * concomitant Rotator cuff tears * skeletally immature patients * glenoid pathology * Shoulder arthritis * active infection
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07488039 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Recurrent Anterior Shoulder Instability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07488039 currently recruiting?
Yes, NCT07488039 is actively recruiting participants. Contact the research team at sherif_shibl@yahoo.com for enrollment information.
Where is the NCT07488039 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07488039 clinical trial?
NCT07488039 is sponsored by Kasr El Aini Hospital. The trial plans to enroll 21 participants.